Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tranexamic Acid to Reduce Blood Loss in Hemorrhagic Caesarean Delivery: a Multicenter Randomized Double Blind Placebo Controlled Therapeutic and Pharmaco-biological Dose Ranging Study (TRACES) for Its Optimal Benefit/Risk

NCT02797119 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT02797119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02797119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tranexamic Acid to Reduce Blood Loss in Hemorrhagic Caesarean Delivery: a Multicenter Randomized Double Blind Placebo Controlled Therapeutic and Pharmaco-biological Dose Ranging Study (TRACES) for Its Optimal Benefit/Risk
Lead sponsor
University Hospital, Lille
Phase
Phase 4
Overall status
Completed
Start date
March 15, 2016
Completion date
April 15, 2021
Enrollment
225 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhage, pregnancy complications